Summit Therapeutics (SMMT) P/E (2020 - 2026)
Summit Therapeutics (SMMT) P/E from Sep 30, 2020 to Jun 2, 2026. The TTM Summit Therapeutics (SMMT) P/E is -9.29. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Summit Therapeutics (SMMT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -9.29 | -23.50% |
| 2025 | -12.14 | -79.28% |
| 2024 | -58.59 | +1801.85% |
| 2023 | -3.08 | -88.81% |
| 2022 | -27.54 | +92.25% |
| 2021 | -14.32 | -73.92% |
| 2020 | -54.93 | N/A |
Comparison Summit Therapeutics (SMMT) P/E with competitors
Summit Therapeutics (SMMT) P/E is -9.29.